The purpose of this study is to evaluate efficacy of orlistat 60 mg as adjuvant treatment of Obesity in adults.

Inclusion Criteria:

• Signed Informed Consent;
• Adults Male and Female ≥ 18 years old;
• Obesity (BMI ≥ 30kg/m2 or ≥ 27 Kg/m2 with associate risk);

Exclusion Criteria:

• Pregnancy and Lactation or women without effective contraception;
• Relevant clinical diseases;
• Obesity associated to genetic syndrome;
• Decompensated Diabetes;
• Psychiatric disorders;
• Alimentary disorders;
• Use of: anorectics, herbal weight loss and/or constipation and laxatives, in the past 30 days;
• Patients using cyclosporine or amiodarone;
• Patients with bowel disease;
• Prior bariatric surgery;
• Anemia;
• Hemoglobinopathies and coagulopathy;
• History of cancer in the past five years;
• Use of corticosteroids, oral or injectable, in the last 30 days.